Mixed Urinary Incontinence

The EAU 2026 non-neurogenic mixed-urinary-incontinence pathway — MUI is coexisting stress and urgency incontinence, characterised where possible as stress- or urgency-predominant, then managed by tackling the most bothersome component first: bladder training and pelvic-floor muscle training for all women, component-directed drug therapy (antimuscarinic or beta-3 agonist for urgency-predominant, duloxetine for stress-predominant), with surgery a warned last resort that is less successful than for stress incontinence alone. Switch between the visual Pathway map and the phase-by-phase Explorer.